Biogen Q3 Earnings: Will Biotech Bounce Back?
Update: 2025-10-10
Description
Biogen's Q3 Earnings: Can This Biotech Giant Recover? Biogen, a $22 billion biotech firm, announces Q3 earnings on October 30, with analysts predicting $3.94 EPS. Despite beating estimates in 3 of the last 4 quarters and raising full-year guidance, Biogen's stock has plummeted 20% in the past year, underperforming the S&P 500 and healthcare sector. Will upcoming earnings revitalize investor confidence? Wall Street analysts see a potential 16% upside, but caution remains.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
